Register information Patent

DE file number : 602 35 013.1 (Status: not pending/lapsed, Query started: April 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTNot pending/lapsed
21DE file number DAKZ602 35 013.1
96EP file numberEAKZ02 75 9206.2
86WO file numberWAKZPCT/US02/24078
97EP publication numberEPN1409018
87WO publication numberWPN2003009817
54Designation/titleTISTABILE LYOPHILISIERTE PHARMAZEUTISCHE FORMULIERUNG DES IGG-ANTIKÖRPERS DACLIZUMAB
51IPC main classICM
(ICMV)
A61K 39/395 (2006.01)
22DE application dateDATJul 25, 2002
96EP application dateEATJul 25, 2002
86WO application dateWATJul 25, 2002
43Date of first publicationOTFeb 6, 2003
Date of publication of grantPETJan 6, 2010
71/73Applicant/ownerINHAbbVie Biotechnology Ltd., Hamilton, Bermuda, US
72InventorINKAISHEVA, Elizabet, A., Belmont, CA 94002, US; FLORES-NATE, Aleni, Union City, CA 94587, US; GUPTA, Supriya, Sunnyvale, CA 94087, US
74RepresentativeVTRHuber & Schüssler, 81825 München, DE
Address for service Patent- und Rechtsanwälte Huber & Schüssler, 81825 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
307878 P
Jul 25, 2001
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
87WO language of publicationWLANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR
Published EP/WO documentsEPWOPNOriginal document: EP000001409018
Searchable text: EP000001409018
Original document: EP000001409018B1
Searchable text: EP000001409018B1
Original document: WO002003009817
Searchable text: WO002003009817
43Date of first publicationEVTFeb 6, 2003
Date of the first transfer into DPMAregisterEREGTSep 29, 2012
Date of the (most recent) update in DPMAregisterREGTJul 27, 2022
(Show all update days)(Hide all update days)
  • Jul 27, 2022; Jan 25, 2022; Jun 19, 2021; Jun 17, 2020; Feb 18, 2020; Aug 9, 2019; Jun 27, 2019; Oct 24, 2018; Jun 28, 2018; Aug 9, 2017; Aug 11, 2016; Dec 23, 2015; Nov 13, 2015; Aug 14, 2015; Aug 19, 2014; Aug 15, 2014; Aug 11, 2014; Sep 26, 2013; Sep 24, 2013; Aug 27, 2013; Aug 8, 2013; Jan 26, 2013
    • Historical data not available for this/these date(s)
  • Sep 29, 2012
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO first publication without search report Feb 6, 2003  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Apr 21, 2004  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 27, 2004 May 27, 2004 Details anzeigen
4 Change of classification Change of IPC main class Oct 17, 2005  Details anzeigen
5 New applicant/owner details New applicant/owner details Dec 10, 2009 Sep 1, 2011 Details anzeigen
6 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 6, 2010  Details anzeigen
7 Publications Publication by DPMA of mention regarding EP patent grant Feb 25, 2010 Feb 25, 2010 Details anzeigen
8 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 6, 2010 Jan 27, 2011 Details anzeigen
9 New applicant/owner details New applicant/owner details Jul 8, 2011 Sep 1, 2011 Details anzeigen
10 New applicant/owner details New applicant/owner details Aug 7, 2013 Sep 26, 2013 Details anzeigen
11 New applicant/owner details New applicant/owner details Nov 12, 2015 Dec 24, 2015 Details anzeigen
12 Administrative procedure IP right lapsed through expiry of term of protection Jul 25, 2022  Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO first publication without search report
Date of legal/procedural statusVSTTFeb 6, 2003
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTApr 21, 2004
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 27, 2004
Issue numberHN22
YearPJ2004
Publication dateVTMay 27, 2004
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTOct 17, 2005
51IPC main classICM
(ICMV)
A61K 39/395 (2006.01)
51Previous IPC main classICMF
(ICMVF)
A61K 39/395 (2000.01)
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTDec 10, 2009
Issue numberHN35
YearPJ2011
Publication dateVTSep 1, 2011
Type of publicationPARTBibliographic data
PartHTPart 2
71/73Previous applicant/ownerINHFProtein Design Labs, Inc., Fremont, Calif., US
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 6, 2010
View procedures Publications (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTFeb 25, 2010
Issue numberHN8
YearPJ2010
Publication dateVTFeb 25, 2010
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 6, 2010
Issue numberHN4
YearPJ2011
Publication dateVTJan 27, 2011
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 8, 2011
Issue numberHN35
YearPJ2011
Publication dateVTSep 1, 2011
Type of publicationPARTBibliographic data
PartHTPart 2
71/73Applicant/ownerINHAbbott Biotherapeutics Corp., Redwood City, Calif., US
71/73Previous applicant/ownerINHFFacet Biotech Corp., Redwood City, Calif., US
View procedures New applicant/owner details (No.: 10)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 7, 2013
Issue numberHN39
YearPJ2013
Publication dateVTSep 26, 2013
Type of publicationPARTBibliographic data
PartHTPart 2
71/73Applicant/ownerINHAbbVie Biotherapeutics Inc., Redwood City, Calif., US
71/73Previous applicant/ownerINHFAbbott Biotherapeutics Corp., Redwood City, Calif., US
View procedures New applicant/owner details (No.: 11)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 12, 2015
Issue numberHN52
YearPJ2015
Publication dateVTDec 24, 2015
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAbbVie Biotechnology Ltd., Hamilton, Bermuda, US
71/73Previous applicant/ownerINHFAbbVie Biotherapeutics Inc., Redwood City, Calif., US
View procedures Administrative procedure (No.: 12)
INIDCriterionFieldContent Close details
Type of procedureVARTAdministrative procedure
Legal/procedural statusVSTIP right lapsed through expiry of term of protection
Date of legal/procedural statusVSTTJul 25, 2022
Date of update of the procedureREGTJul 27, 2022